DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 123 filers reported holding DERMIRA INC in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $9,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,534,664 | $44,720,000 | 5.35% |
| Avoro Capital Advisors LLC | 1,325,000 | $38,611,000 | 4.88% |
| NEA Management Company, LLC | 3,506,649 | $102,184,000 | 3.72% |
| Iguana Healthcare Management, LLC | 140,000 | $4,080,000 | 2.31% |
| Foresite Capital Management II, LLC | 135,294 | $3,942,000 | 1.81% |
| Foresite Capital Management III, LLC | 176,211 | $5,135,000 | 1.68% |
| Abingworth LLP | 70,000 | $2,038,000 | 1.62% |
| DAFNA Capital Management LLC | 75,500 | $2,200,000 | 1.57% |
| NEXTHERA CAPITAL LP | 120,600 | $3,514,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 129,000 | $3,756,000 | 1.43% |